CLINICAL_TRIALS
trial_result
· 2024-04-08
Clinical Trial Update: Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children [Phase 1]
Summary
Phase 1b trial update for PVSRIPO in recurrent malignant glioma in children has completed enrollment and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Istari Oncology, Inc. | Conditions: Malignant Glioma, Anaplastic Astrocytoma | Phase 1 | Status: COMPLETED | Results posted: 2024-04-08